loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE

    Menu

    3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 158,313Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22522 / DOSAGE - TABLET;ORAL - 250MCG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    roflumilast(UNII: 0P6C6ZOP5U)
    (roflumilast - UNII:0P6C6ZOP5U)     		roflumilast500ug

    Inactive Ingredients

    Ingredient Name
    Torrent Pharmaceuticals Limited
    Strides Pharma Science Limited
    ALLERGAN, INC.
    Cardinal Health
    CARBOXYMETHYLCELLULOSE CALCIUM(UTY7PDF93L)   
    HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)   
    lactose monohydrate(EWQ57Q8I5X)
    magnesium stearate(70097M6I30)
    POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)   
    povidone(FZ989GH94E)   
    POVIDONE, UNSPECIFIED(FZ989GH94E)   
    STARCH, CORN(O8232NY3SJ)